Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - thiacetarsamide sodium - unknown - thiacetarsamide sodium anthelmintic active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - thiacetarsamide sodium - parenteral liquid/solution/suspension - thiacetarsamide sodium anthelmintic active 10.0 mg/ml - parasiticides - dog | bitch | castrate | puppy - heartworm

Canada - English - Health Canada

p.v.u., division of vÉtoquinol n.-a. inc. - thiacetarsamide sodium - liquid - 10mg - thiacetarsamide sodium 10mg - dogs

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - gelsemium sempervirens 3x natrum carbonicum 3x nux vomica 6x chelidonium majus 10x aspartame 12x cyclamate 12x cysteine 12x sulphur 12x thioacetamide 12x thioglycolic acid 12x - for the temporary relief of occasional headache, nasal congestion, shortness of breath, skin irritation, weakness, nausea, or diarrhea.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - disulfiram 200mg;   - effervescent tablet - 200 mg - active: disulfiram 200mg   excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose polysorbate 20 povidone purified talc sodium bicarbonate tartaric acid - deterrent to alcohol consumption and an aid in the overall management of selected chronic alcoholic patients involved in an integrated program of counselling and psychiatry. only alcoholic patients who are motivated to abstain from drinking and who are undergoing supportive psychotherapeutic treatment ancillary to a total program of rehabilitation should be selected for antabuse administration.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - disulfiram, quantity: 200 mg - tablet, effervescent - excipient ingredients: tartaric acid; magnesium stearate; povidone; maize starch; microcrystalline cellulose; sodium bicarbonate; colloidal anhydrous silica; purified talc; polysorbate 20 - antabuse tablets are indicated as a deterrent to alcohol comsumption and as an aid in the overall management of selected chronic alcoholic patients involved in an integrated program of counselling and psychiatry. only alcoholic patients who are motivated to abstain from drinking and who are undergoing supportive psychotherapeutic treatment, ancillary to a total program of rehabilitation, should be selected for antabuse administration.

United States - English - NLM (National Library of Medicine)

rebel distributors corp. - propylthiouracil (unii: 721m9407iy) (propylthiouracil - unii:721m9407iy) - propylthiouracil 50 mg - propylthiouracil is indicated: - in patients with graves' disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option. - to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole. propylthiouracil is contraindicated in patients who have demonstrated hypersensitivity to the drug or any of the other product components.

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - propylthiouracil (unii: 721m9407iy) (propylthiouracil - unii:721m9407iy) - propylthiouracil 50 mg - propylthiouracil is indicated: - in patients with graves’ disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option - to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole propylthiouracil is contraindicated in patients who have demonstrated hypersensitivity to the drug or any of the other product components.

United States - English - NLM (National Library of Medicine)

american health packaging - propylthiouracil (unii: 721m9407iy) (propylthiouracil - unii:721m9407iy) - propylthiouracil 50 mg - propylthiouracil is indicated: - in patients with graves’ disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option - to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole propylthiouracil is contraindicated in patients who have demonstrated hypersensitivity to the drug or any of the other product components.

United States - English - NLM (National Library of Medicine)

west-ward pharmaceutical corp - propylthiouracil (unii: 721m9407iy) (propylthiouracil - unii:721m9407iy) - propylthiouracil 50 mg - propylthiouracil is indicated: - in patients with graves' disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option. - to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole. propylthiouracil is contraindicated in patients who have demonstrated hypersensitivity to the drug or any of the other product components.